Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Bur

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Journal of Medicinal Chemistry|July 14, 2000
Novel inhibitors of DNA gyrase: 3D structure based biased needle screening, hit validation by biophysical methods, and 3D guided optimization. A promising alternative to random screeningH J Boehm, M Boehringer, D Bur, et al.
Biochemical and Biophysical Research Communications|May 30, 1989
On the effect on specificity of Thr246----Gly mutation in L-lactate dehydrogenase of Bacillus sterothermophilusD Bur, T Clarke, J D Friesen, et al.
Journal of Medicinal Chemistry|July 6, 2000
Hydroxamic acid derivatives as potent peptide deformylase inhibitors and antibacterial agentsC Apfel, D W Banner, D Bur, et al.
The Journal of Biological Chemistry|October 24, 2000
The potency and specificity of the interaction between the IA3 inhibitor and its target aspartic proteinase from Saccharomyces cerevisiaeL H Phylip, W E Lees, B G Brownsey, et al.
Bioorganic & Medicinal Chemistry Letters|June 9, 1999
Substituted piperidines--highly potent renin inhibitors due to induced fit adaptation of the active siteE Vieira, A Binggeli, V Breu, et al.
European Journal of Biochemistry|March 1, 1997
Expression and characterisation of plasmepsin I from Plasmodium falciparumR P Moon, L Tyas, U Certa, et al.
Bioorganic & Medicinal Chemistry Letters|June 9, 1999
Piperidine-renin inhibitors compounds with improved physicochemical propertiesR Güller, A Binggeli, V Breu, et al.
Advances in Experimental Medicine and Biology|April 30, 1998
Studies on plasmepsins I and II from the malarial parasite Plasmodium falciparum and their exploitation as drug targetsR P Moon, D Bur, H Loetscher, et al.
Chemistry & Biology|March 13, 1999
Renin inhibition by substituted piperidines: a novel paradigm for the inhibition of monomeric aspartic proteinases?C Oefner, A Binggeli, V Breu, et al.
Farmaco (Societa Chimica Italiana : 1989)|May 12, 2001
Piperidine renin inhibitors: from leads to drug candidatesH P Märki, A Binggeli, B Bittner, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Journal of Medicinal Chemistry|July 14, 2000
Novel inhibitors of DNA gyrase: 3D structure based biased needle screening, hit validation by biophysical methods, and 3D guided optimization. A promising alternative to random screeningH J Boehm, M Boehringer, D Bur, et al.
Biochemical and Biophysical Research Communications|May 30, 1989
On the effect on specificity of Thr246----Gly mutation in L-lactate dehydrogenase of Bacillus sterothermophilusD Bur, T Clarke, J D Friesen, et al.
Journal of Medicinal Chemistry|July 6, 2000
Hydroxamic acid derivatives as potent peptide deformylase inhibitors and antibacterial agentsC Apfel, D W Banner, D Bur, et al.
The Journal of Biological Chemistry|October 24, 2000
The potency and specificity of the interaction between the IA3 inhibitor and its target aspartic proteinase from Saccharomyces cerevisiaeL H Phylip, W E Lees, B G Brownsey, et al.
Bioorganic & Medicinal Chemistry Letters|June 9, 1999
Substituted piperidines--highly potent renin inhibitors due to induced fit adaptation of the active siteE Vieira, A Binggeli, V Breu, et al.
European Journal of Biochemistry|March 1, 1997
Expression and characterisation of plasmepsin I from Plasmodium falciparumR P Moon, L Tyas, U Certa, et al.
Bioorganic & Medicinal Chemistry Letters|June 9, 1999
Piperidine-renin inhibitors compounds with improved physicochemical propertiesR Güller, A Binggeli, V Breu, et al.
Advances in Experimental Medicine and Biology|April 30, 1998
Studies on plasmepsins I and II from the malarial parasite Plasmodium falciparum and their exploitation as drug targetsR P Moon, D Bur, H Loetscher, et al.
Chemistry & Biology|March 13, 1999
Renin inhibition by substituted piperidines: a novel paradigm for the inhibition of monomeric aspartic proteinases?C Oefner, A Binggeli, V Breu, et al.
Farmaco (Societa Chimica Italiana : 1989)|May 12, 2001
Piperidine renin inhibitors: from leads to drug candidatesH P Märki, A Binggeli, B Bittner, et al.
Pageof 3